helminth-based oral therapy
Pre-clinical- Indications
- Crohn's disease, Ulcerative colitis
Company intelligence / Profile preview
Asphelia Pharmaceuticals, Inc.
San Diego, California, United Statesinsights.citeline.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Asphelia Pharmaceuticals developed novel therapeutics targeting immunological and inflammatory diseases. Its lead programs included ASP‑1001 nasal spray for allergic rhinitis and Trichuris Suis Ova therapy for Crohn's disease. Clinical trials reached up to Phase 2/3, with at least one trial completed. The company was acquired by Coronado Biosciences/Fortress Biotech around or before the early/mid‑2010s, and does not appear to be independently active today.
- Therapeutic areas
- GastroenterologyImmunology
- Modalities
- Small moleculesBiological therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
University of Chicago collaborated on clinical trial of ASP‑1001; no major pharma partnerships disclosed
Beyond the preview
Go deeper on Asphelia Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Asphelia Pharmaceuticals, Inc..